125 related articles for article (PubMed ID: 10665658)
1. Evaluation of antivascular and antimitotic effects of tubulin binding agents in solid tumor therapy.
Nihei Y; Suzuki M; Okano A; Tsuji T; Akiyama Y; Tsuruo T; Saito S; Hori K; Sato Y
Jpn J Cancer Res; 1999 Dec; 90(12):1387-95. PubMed ID: 10665658
[TBL] [Abstract][Full Text] [Related]
2. Antivascular effects of TZT-1027 (Soblidotin) on murine Colon26 adenocarcinoma.
Watanabe J; Natsume T; Kobayashi M
Cancer Sci; 2006 Dec; 97(12):1410-6. PubMed ID: 16999818
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the antivascular and cytotoxic activities of TZT-1027 (Soblidotin) with those of other anticancer agents.
Watanabe J; Natsume T; Kobayashi M
Anticancer Drugs; 2007 Sep; 18(8):905-11. PubMed ID: 17667596
[TBL] [Abstract][Full Text] [Related]
4. A novel combretastatin A-4 derivative, AC-7700, shows marked antitumor activity against advanced solid tumors and orthotopically transplanted tumors.
Nihei Y; Suga Y; Morinaga Y; Ohishi K; Okano A; Ohsumi K; Hatanaka T; Nakagawa R; Tsuji T; Akiyama Y; Saito S; Hori K; Sato Y; Tsuruo T
Jpn J Cancer Res; 1999 Sep; 90(9):1016-25. PubMed ID: 10551333
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumor and anti-vascular effects of the novel tubulin-binding agent combretastatin A-1 phosphate.
Holwell SE; Cooper PA; Thompson MJ; Pettit GR; Lippert LW; Martin SW; Bibby MC
Anticancer Res; 2002; 22(6C):3933-40. PubMed ID: 12553015
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of diarylthiazole derivatives as antimitotic and antivascular agents with potent antitumor activity.
Wang F; Yang Z; Liu Y; Ma L; Wu Y; He L; Shao M; Yu K; Wu W; Pu Y; Nie C; Chen L
Bioorg Med Chem; 2015 Jul; 23(13):3337-50. PubMed ID: 25937236
[TBL] [Abstract][Full Text] [Related]
7. ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature.
Davis PD; Dougherty GJ; Blakey DC; Galbraith SM; Tozer GM; Holder AL; Naylor MA; Nolan J; Stratford MR; Chaplin DJ; Hill SA
Cancer Res; 2002 Dec; 62(24):7247-53. PubMed ID: 12499266
[TBL] [Abstract][Full Text] [Related]
8. A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors.
Tahir SK; Han EK; Credo B; Jae HS; Pietenpol JA; Scatena CD; Wu-Wong JR; Frost D; Sham H; Rosenberg SH; Ng SC
Cancer Res; 2001 Jul; 61(14):5480-5. PubMed ID: 11454695
[TBL] [Abstract][Full Text] [Related]
9. Antitumor and antivascular effects of AC-7700, a combretastatin A-4 derivative, against rat liver cancer.
Ohno T; Kawano K; Sasaki A; Aramaki M; Tahara K; Etoh T; Kitano S
Int J Clin Oncol; 2002 Jun; 7(3):171-6. PubMed ID: 12109519
[TBL] [Abstract][Full Text] [Related]
10. In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors.
Koyanagi N; Nagasu T; Fujita F; Watanabe T; Tsukahara K; Funahashi Y; Fujita M; Taguchi T; Yoshino H; Kitoh K
Cancer Res; 1994 Apr; 54(7):1702-6. PubMed ID: 8137285
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of E7010, an orally active sulfonamide antitumor agent: inhibition of mitosis by binding to the colchicine site of tubulin.
Yoshimatsu K; Yamaguchi A; Yoshino H; Koyanagi N; Kitoh K
Cancer Res; 1997 Aug; 57(15):3208-13. PubMed ID: 9242451
[TBL] [Abstract][Full Text] [Related]
12. Hypoestoxide, a natural nonmutagenic diterpenoid with antiangiogenic and antitumor activity: possible mechanisms of action.
Ojo-Amaize EA; Nchekwube EJ; Cottam HB; Bai R; Verdier-Pinard P; Kakkanaiah VN; Varner JA; Leoni L; Okogun JI; Adesomoju AA; Oyemade OA; Hamel E
Cancer Res; 2002 Jul; 62(14):4007-14. PubMed ID: 12124334
[TBL] [Abstract][Full Text] [Related]
13. Antivascular and antitumor properties of the tubulin-binding chalcone TUB091.
Canela MD; Noppen S; Bueno O; Prota AE; Bargsten K; Sáez-Calvo G; Jimeno ML; Benkheil M; Ribatti D; Velázquez S; Camarasa MJ; Díaz JF; Steinmetz MO; Priego EM; Pérez-Pérez MJ; Liekens S
Oncotarget; 2017 Feb; 8(9):14325-14342. PubMed ID: 27224920
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of angiogenesis and intrahepatic growth of colon cancer by TAC-101.
Murakami K; Sakukawa R; Sano M; Hashimoto A; Shibata J; Yamada Y; Saiki I
Clin Cancer Res; 1999 Sep; 5(9):2304-10. PubMed ID: 10499597
[TBL] [Abstract][Full Text] [Related]
15. Novel tubulin antagonist pretubulysin displays antivascular properties in vitro and in vivo.
Kretzschmann VK; Gellrich D; Ullrich A; Zahler S; Vollmar AM; Kazmaier U; Fürst R
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):294-303. PubMed ID: 24285578
[TBL] [Abstract][Full Text] [Related]
16. Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin.
Gupta K; Bishop J; Peck A; Brown J; Wilson L; Panda D
Biochemistry; 2004 Jun; 43(21):6645-55. PubMed ID: 15157098
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of in vivo antitumor activity of a novel antimitotic 1-phenylpropenone derivative, AM-132, by tumor necrosis factor-alpha or interleukin-6.
Tatsumi Y; Arioka H; Ikeda S; Fukumoto H; Miyamoto K; Fukuoka K; Ohe Y; Saijo N; Nishio K
Jpn J Cancer Res; 2001 Jul; 92(7):768-77. PubMed ID: 11473728
[TBL] [Abstract][Full Text] [Related]
18. ABT-751, a novel tubulin-binding agent, decreases tumor perfusion and disrupts tumor vasculature.
Luo Y; Hradil VP; Frost DJ; Rosenberg SH; Gordon GB; Morgan SJ; Gagne GD; Cox BF; Tahir SK; Fox GB
Anticancer Drugs; 2009 Jul; 20(6):483-92. PubMed ID: 19398903
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol analog (Z)-3,5,4'-trimethoxystilbene is a potent anti-mitotic drug inhibiting tubulin polymerization.
Schneider Y; Chabert P; Stutzmann J; Coelho D; Fougerousse A; Gossé F; Launay JF; Brouillard R; Raul F
Int J Cancer; 2003 Nov; 107(2):189-96. PubMed ID: 12949793
[TBL] [Abstract][Full Text] [Related]
20. Effect of E7010 on liver metastasis and life span of syngeneic C57BL/6 mice bearing orthotopically transplanted murine Colon 38 tumor.
Funahashi Y; Koyanagi N; Kitoh K
Cancer Chemother Pharmacol; 2001; 47(2):179-84. PubMed ID: 11269745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
